Cargando…

Prevalence and Epidemiology of Injuries Among Elite Cyclists in the Tour de France

BACKGROUND: Cycling injuries are increasing, particularly among elite athletes during major events such as the Tour de France. Many athletes miss considerable time from sport and require surgical intervention. Little is known about the epidemiology of injuries to guide practice participation strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Haeberle, Heather S., Navarro, Sergio M., Power, Eric J., Schickendantz, Mark S., Farrow, Lutul D., Ramkumar, Prem N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124184/
https://www.ncbi.nlm.nih.gov/pubmed/30202769
http://dx.doi.org/10.1177/2325967118793392
_version_ 1783352990346772480
author Haeberle, Heather S.
Navarro, Sergio M.
Power, Eric J.
Schickendantz, Mark S.
Farrow, Lutul D.
Ramkumar, Prem N.
author_facet Haeberle, Heather S.
Navarro, Sergio M.
Power, Eric J.
Schickendantz, Mark S.
Farrow, Lutul D.
Ramkumar, Prem N.
author_sort Haeberle, Heather S.
collection PubMed
description BACKGROUND: Cycling injuries are increasing, particularly among elite athletes during major events such as the Tour de France. Many athletes miss considerable time from sport and require surgical intervention. Little is known about the epidemiology of injuries to guide practice participation strategies, return-to-competition expectations, and injury prevention protocols. PURPOSE: To evaluate the injury epidemiology, operative incidence, and return-to-competition timeline among all elite cyclists participating in the 21-stage Tour de France race over a span of 8 years. STUDY DESIGN: Descriptive epidemiological study. METHODS: All injuries sustained during 1584 unique rides by cyclists participating in the Tour de France from 2010 to 2017 were evaluated. In the absence of an established Tour de France injury database, demographic, injury, surgical, and return-to-competition details from all athletes who withdrew because of a traumatic injury were retrospectively compiled using publicly available data, which were cross-referenced for validity. The inclusion criterion consisted of any cyclist who withdrew from the Tour de France because of an injury; cyclists who withdrew for noninjury reasons were excluded. Independent variables included injury demographics, missed days, and whether the injury required surgery. Injury prevalence, relative frequency distributions, and sample proportions were dependent metrics for this investigation. RESULTS: Among the 1584 cycling entries evaluated over the 8-year study period, there were 259 cyclists (16%) who withdrew (17 cyclists/year). A total of 138 withdrawals were caused by acute trauma, 49% of which were fractures (n = 67), which represented the most common reason for withdrawal. A total of 29 (43%) cyclists with fractures underwent surgery. The most commonly fractured bones were the clavicle (n = 21), followed by the wrist (n = 6), hand (n = 5), femur (n = 5), humerus (n = 5), and ribs (n = 5). Cyclists who underwent operative fracture fixation had a longer time between the injury and their next race compared with those who did not undergo surgery (77 vs 44 days, respectively; P = .065). CONCLUSION: The most common injury leading to withdrawal from the Tour de France over the study period was acute fracture, comprising 49% of all injuries. Almost half of the cyclists with fractures underwent surgery. The clavicle was the most commonly fractured bone. For cyclists who underwent operative treatment of their fractures, return to competition was more than 1 month longer than for those who did not. A prospective database is warranted to catalog injuries among these elite cyclists.
format Online
Article
Text
id pubmed-6124184
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61241842018-09-10 Prevalence and Epidemiology of Injuries Among Elite Cyclists in the Tour de France Haeberle, Heather S. Navarro, Sergio M. Power, Eric J. Schickendantz, Mark S. Farrow, Lutul D. Ramkumar, Prem N. Orthop J Sports Med Article BACKGROUND: Cycling injuries are increasing, particularly among elite athletes during major events such as the Tour de France. Many athletes miss considerable time from sport and require surgical intervention. Little is known about the epidemiology of injuries to guide practice participation strategies, return-to-competition expectations, and injury prevention protocols. PURPOSE: To evaluate the injury epidemiology, operative incidence, and return-to-competition timeline among all elite cyclists participating in the 21-stage Tour de France race over a span of 8 years. STUDY DESIGN: Descriptive epidemiological study. METHODS: All injuries sustained during 1584 unique rides by cyclists participating in the Tour de France from 2010 to 2017 were evaluated. In the absence of an established Tour de France injury database, demographic, injury, surgical, and return-to-competition details from all athletes who withdrew because of a traumatic injury were retrospectively compiled using publicly available data, which were cross-referenced for validity. The inclusion criterion consisted of any cyclist who withdrew from the Tour de France because of an injury; cyclists who withdrew for noninjury reasons were excluded. Independent variables included injury demographics, missed days, and whether the injury required surgery. Injury prevalence, relative frequency distributions, and sample proportions were dependent metrics for this investigation. RESULTS: Among the 1584 cycling entries evaluated over the 8-year study period, there were 259 cyclists (16%) who withdrew (17 cyclists/year). A total of 138 withdrawals were caused by acute trauma, 49% of which were fractures (n = 67), which represented the most common reason for withdrawal. A total of 29 (43%) cyclists with fractures underwent surgery. The most commonly fractured bones were the clavicle (n = 21), followed by the wrist (n = 6), hand (n = 5), femur (n = 5), humerus (n = 5), and ribs (n = 5). Cyclists who underwent operative fracture fixation had a longer time between the injury and their next race compared with those who did not undergo surgery (77 vs 44 days, respectively; P = .065). CONCLUSION: The most common injury leading to withdrawal from the Tour de France over the study period was acute fracture, comprising 49% of all injuries. Almost half of the cyclists with fractures underwent surgery. The clavicle was the most commonly fractured bone. For cyclists who underwent operative treatment of their fractures, return to competition was more than 1 month longer than for those who did not. A prospective database is warranted to catalog injuries among these elite cyclists. SAGE Publications 2018-09-04 /pmc/articles/PMC6124184/ /pubmed/30202769 http://dx.doi.org/10.1177/2325967118793392 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (http://www.creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Haeberle, Heather S.
Navarro, Sergio M.
Power, Eric J.
Schickendantz, Mark S.
Farrow, Lutul D.
Ramkumar, Prem N.
Prevalence and Epidemiology of Injuries Among Elite Cyclists in the Tour de France
title Prevalence and Epidemiology of Injuries Among Elite Cyclists in the Tour de France
title_full Prevalence and Epidemiology of Injuries Among Elite Cyclists in the Tour de France
title_fullStr Prevalence and Epidemiology of Injuries Among Elite Cyclists in the Tour de France
title_full_unstemmed Prevalence and Epidemiology of Injuries Among Elite Cyclists in the Tour de France
title_short Prevalence and Epidemiology of Injuries Among Elite Cyclists in the Tour de France
title_sort prevalence and epidemiology of injuries among elite cyclists in the tour de france
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124184/
https://www.ncbi.nlm.nih.gov/pubmed/30202769
http://dx.doi.org/10.1177/2325967118793392
work_keys_str_mv AT haeberleheathers prevalenceandepidemiologyofinjuriesamongelitecyclistsinthetourdefrance
AT navarrosergiom prevalenceandepidemiologyofinjuriesamongelitecyclistsinthetourdefrance
AT powerericj prevalenceandepidemiologyofinjuriesamongelitecyclistsinthetourdefrance
AT schickendantzmarks prevalenceandepidemiologyofinjuriesamongelitecyclistsinthetourdefrance
AT farrowlutuld prevalenceandepidemiologyofinjuriesamongelitecyclistsinthetourdefrance
AT ramkumarpremn prevalenceandepidemiologyofinjuriesamongelitecyclistsinthetourdefrance